Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-12

Clinical Trial Update: Simvastatin For Intracerebral Hemorrhage Study [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating simvastatin for intracerebral hemorrhage was terminated, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Johns Hopkins University | Conditions: Intracerebral Hemorrhage | Phase 2 | Status: TERMINATED | Results posted: 2017-06-12